Drug Profile
Research programme: emt protein-tyrosine kinase inhibitors - Bristol-Myers Squibb
Alternative Names: BMS 285047; BMS 431051; BMS 509744Latest Information Update: 21 Jan 2008
Price :
$50
*
At a glance
- Originator Bristol-Myers Squibb
- Class Small molecules; Thiazoles
- Mechanism of Action Emt protein-tyrosine kinase inhibitors; Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Immunosuppression